查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2143832

獸用生技藥品市場：全球市場預測，2026-2032年

Veterinary Biological Product Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，獸用生技藥品市場將成長至 41.3 億美元，複合年成長率為 4.90%。

主要市場統計數據
基準年 2025 29.5億美元
預計年份：2026年 31.7億美元
預測年份 2032 41.3億美元
複合年成長率 (%) 4.90%

獸用生技藥品：概述

獸用生技藥品包括疫苗、抗血清、免疫試劑及相關生物製藥，用於預防、診斷或控制動物疾病。隨著動物保健計畫的推進，其重要性日益凸顯，這些計畫旨在應對畜牧生產力、伴侶動物照護、通用感染疾病風險、食品安全以及動物和動物產品的國際流動等挑戰。需求量因動物種類、疾病負擔、獸醫基礎設施、監管要求以及預防醫學實踐的普及程度而異。

預防、監管和「一體化健康」正在改變產業格局。

該領域正從被動治療轉向預防、監測和協調的疾病管理。隨著人們越來越重視合理使用抗生素、生物安全、可追溯性、動物福利和通用感染疾病防範，生物製藥在國家和農場層面的健康計劃中的作用日益增強。監管要求也強調產品品質、安全性、有效性、冷鏈完整性、藥物安全監測和實證用藥。這些變化需要能夠融入免疫接種計劃、畜群健康管理方案、診斷流程和公共衛生系統的解決方案。

利用人工智慧 (AI) 改進藥物發現、診斷和遞送

人工智慧可以透過抗原候選物鑑定、病原體序列分析、免疫反應建模和實驗室實驗優先排序等方式支持獸用生技藥品的研發。在實用化中，機器學習工具可用於解讀診斷數據、檢測疾病模式、最佳化疫苗接種時間，並識別畜群和族群中疫苗接種覆蓋率的不足之處。這些應用的價值取決於代表性的數據、檢驗的模型、可互通的記錄、網路安全以及獸醫監管。因此，人工智慧應「補充」而非「取代」臨床判斷、檢查室驗證、監管審查和負責任的管理。

區域洞察：基礎設施差異導致優先事項不同

在北美，先進的獸醫基礎設施、完善的監管體係以及畜牧業、水產養殖業和伴侶動物的廣泛需求，使得疾病監測和合理使用抗生素成為重中之重。在拉丁美洲，畜牧業健康、出口合規、生物安全以及不同生產體系的可近性備受重視。在歐洲，動物福利、可追溯性、科學依據和統一的監管流程是優先事項。在中東，需要針對進口動物、跨境疾病風險、水資源和氣候限制以及不斷擴大的糧食安全計畫制定合適的解決方案。在非洲，獸醫服務取得管道不均以及冷鏈限制，使得畜牧業疾病管理和監測的需求特別迫切。亞太地區擁有高度發展的市場和快速發展的生產體系，因此需要可擴展的預防性措施、本地化生產能力以及應對高密度動物族群和新興病原體的方案。

集團洞察：協調貿易、安全與監管

東協多樣化的生產體系和跨境動物流動需要區域性監測、統一標準和切實可行的冷鏈網路。金磚國家成員國在畜牧業、水產養殖和伴侶動物方面有著顯著的需求，其優先事項受國內生產、糧食安全、疾病管制和監管協調的影響。歐盟強調通用標準、可追溯性、動物福利和協調的疾病控制架構。七國集團成員國普遍擁有成熟的監管和獸醫體系，重點關注創新、韌性、合理使用抗菌藥物以及「同一健康」的準備。海灣合作理事會國家關注糧食安全、進口牲畜、生物安全和可靠的供應路線。北約成員國的動物健康狀況各不相同，但在韌性、緊急準備、供應連續性和防範跨境生物威脅方面有著通用的利益。

國家概況：不同疾病防治和取得的優先事項

澳洲優先考慮畜牧業生物安全、出口保障、野生動物接觸以及提供地域分散的獸醫服務。巴西的重點是牛、家禽、豬、水產養殖、區域疾病控制以及進入國際市場。加拿大將畜牧業和伴侶動物的需求與監測、寒冷氣候下的物流以及強力的法律規範相結合。中國致力於大規模生產、疾病預防、國內產能以及獸醫服務的現代化。法國、德國、義大利和西班牙在歐洲法規結構內，優先考慮畜牧業、伴侶動物、福利和生物安全。由於印度畜牧業種類繁多且獸醫服務覆蓋範圍不均衡，因此在擴大預防醫學和向農村地區提供服務方面面臨巨大需求。日本優先考慮高品質標準、老化社會、伴侶動物照護以及應對動物疫病爆發的準備工作。墨西哥正在平衡畜牧業生產、跨境貿易和多元化的區域准入。俄羅斯的優先事項包括國內生產能力、動物疫病控制和地理廣泛的服務提供。韓國將集約化生產、嚴格的生物安全措施和技術驅動的獸醫服務結合。英國著重於生物安全、監測、監管保障和動物福利。美國對牲畜、家禽、水產養殖和伴侶動物的需求廣泛，並擁有完善的監管、診斷和疾病控制體系。

領導者行動指南：建構具有韌性、以證據為基礎的預防體系

行業領導者必須將產品開發與明確的疾病控制目標、特定物種的應用案例以及監管證據要求保持一致。加強配方穩定性、冷鏈性能、本地技術支援和培訓，有助於在分銷基礎設施不完善的地區推廣產品。與獸醫機構、實驗室、生產商、大學和公共衛生機構夥伴關係，可以改善監測和應對協調。領導者也應建立透明的管理政策、上市後監測、負責任的資料管治和人工智慧檢驗方案。確保產品系列的韌性需要專注於關鍵投入、生產連續性、區域註冊流程以及應對感染疾病和物流中斷的緊急時應對計畫。

調查方法：對檢驗的市場證據進行結構化審查

本執行摘要基於已定義的獸用生技藥品類別以及所需的區域、群體和國家/地區特定範圍。分析採用結構化框架，將產品應用與疾病預防、獸醫基礎設施、法規、貿易、生物安全、「同一健康」優先事項和技術應用連結起來。地理觀察以定性方式呈現，僅限於已確定的市場促進因素和商業環境。本報告不包含市場估算、預測、市場規模、市場佔有率、展望或公司特定聲明。在做出策略決策之前，應根據現行法律法規、官方疾病監測、獸醫主管機關和產品註冊記錄來驗證本報告解讀的有效性。

結論：預防和系統整合將決定未來的競爭格局。

獸用生技藥品在建構具有韌性的動物健康體系中發揮著日益重要的核心作用，它將疾病預防、食品安全、動物福利、通用感染疾病管理和合理使用抗生素緊密聯繫起來。鑑於區域和國家之間的顯著差異，適應性強的產品、可靠的供應鏈、強力的證據以及監管協調至關重要。那些將科學嚴謹性與監測系統、數位化能力、本地夥伴關係關係和供應鏈韌性相結合的機構，將更有能力支持有效且永續的動物健康成果。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 獸用生技藥品市場：依產品類型分類

  • 抗毒素
  • 診斷
  • 疫苗

第8章 獸用生技藥品市場：依動物類型分類

  • 水產養殖
  • 伴侶動物
    • 狗
    • 馬
    • 貓
  • 家畜
    • 牛
    • 山羊
    • 羊
    • 豬
  • 家禽

第9章 獸用生技藥品市場：依疾病適應症分類

  • 細菌性疾病
    • 炭疽病
    • 布氏桿菌症
    • 沙門氏菌病
  • 寄生蟲病
  • 病毒性疾病
    • 口蹄疫
    • 新城疫
    • 狂犬病

第10章 獸用生技藥品市場：依最終用戶分類

  • 診所
  • 農民
  • 政府機構
  • 動物醫院

第11章 獸用生技藥品市場：依給藥途徑分類

  • 注射
    • 肌肉內部
    • 靜脈
    • 皮下
  • 鼻內
  • 口服

第12章 獸用生技藥品市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 獸用生技藥品市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 獸用生技藥品市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Animalcare Ltd
  • Bimeda Inc
  • Biogenesis Bago SA
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Chongqing Zhifei Biological Products Co Ltd
  • Dechra Pharmaceuticals plc
  • Eco Animal Health Group Limited
  • Elanco Animal Health Incorporated
  • Hester Biosciences Ltd
  • HIPRA SA
  • Indian Immunologicals Ltd
  • Kyoritsu Seiyaku Corporation
  • Merck & Co Inc
  • Neogen Corporation
  • Norbrook Laboratories Ltd
  • Phibro Animal Health Corporation
  • Shenzhen Kangtai Biological Products Co Ltd
  • Tianjin Ringpu Bio-Technology Co Ltd
  • Utrecht Biologicals BV
  • Vetanco SA
  • Vetoquinol SA
  • Virbac SA
  • Zoetis Inc

第17章 主要專家

Product Code: MRR-9C4233EE7DB9

The Veterinary Biological Product Market is projected to grow by USD 4.13 billion at a CAGR of 4.90% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.95 billion
Estimated Year [2026] USD 3.17 billion
Forecast Year [2032] USD 4.13 billion
CAGR (%) 4.90%

Veterinary Biological Products: Executive Overview

Veterinary biological products include vaccines, antisera, immunological reagents, and related biological preparations used to prevent, diagnose, or control animal diseases. Their importance is increasing as animal health programs address livestock productivity, companion-animal care, zoonotic disease risks, food safety, and international movement of animals and animal products. Demand conditions differ by species, disease burden, veterinary infrastructure, regulatory requirements, and the adoption of preventive healthcare practices.

Prevention, Regulation, and One Health Reshape the Landscape

The sector is shifting from reactive treatment toward prevention, surveillance, and coordinated disease control. Stronger attention to antimicrobial stewardship, biosecurity, traceability, animal welfare, and zoonotic disease preparedness is increasing the role of biological products in national and farm-level health programs. Regulatory expectations are also emphasizing product quality, safety, efficacy, cold-chain integrity, pharmacovigilance, and evidence-based use. These changes favor solutions that can be integrated into vaccination schedules, herd-health protocols, diagnostic workflows, and public-health systems.

Artificial Intelligence Improves Discovery, Diagnostics, and Deployment

Artificial intelligence can support veterinary biological product development by identifying antigen candidates, analyzing pathogen sequences, modeling immune responses, and prioritizing laboratory experiments. In deployment, machine-learning tools can help interpret diagnostic data, detect disease patterns, optimize vaccination timing, and identify gaps in herd or population coverage. The value of these applications depends on representative data, validated models, interoperable records, cybersecurity, and veterinary oversight. AI should therefore complement-not replace-clinical judgment, laboratory confirmation, regulatory review, and responsible stewardship.

Regional Insights: Uneven Infrastructure Creates Distinct Priorities

North America combines advanced veterinary infrastructure, established regulatory systems, and demand across livestock, aquaculture, and companion animals, while disease surveillance and antimicrobial stewardship remain central priorities. Latin America places strong emphasis on livestock health, export compliance, biosecurity, and access across diverse production systems. Europe prioritizes animal welfare, traceability, scientific substantiation, and harmonized regulatory processes. The Middle East requires solutions suited to imported animals, transboundary disease risks, water and climate constraints, and expanding food-security programs. Africa faces varied access to veterinary services, cold-chain limitations, and significant needs in livestock disease control and surveillance. Asia-Pacific spans highly advanced markets and rapidly developing production systems, creating demand for scalable prevention, local manufacturing capacity, and responses to dense animal populations and emerging pathogens.

Group Insights: Trade, Security, and Regulatory Coordination

ASEAN's diverse production systems and cross-border animal movement make regional surveillance, harmonized standards, and practical cold-chain networks important. BRICS members have substantial livestock, aquaculture, and companion-animal needs, with priorities shaped by domestic manufacturing, food security, disease control, and regulatory coordination. The European Union emphasizes common standards, traceability, animal welfare, and coordinated disease-management frameworks. G7 members generally have mature regulatory and veterinary systems, with focus on innovation, resilience, antimicrobial stewardship, and One Health preparedness. GCC countries place emphasis on food security, imported livestock, biosecurity, and reliable supply channels. NATO members have varied animal-health profiles but share interests in resilience, emergency preparedness, supply continuity, and protection against transboundary biological threats.

Country Insights: Diverse Disease-Control and Access Priorities

Australia emphasizes livestock biosecurity, export assurance, wildlife interfaces, and geographically dispersed veterinary delivery. Brazil focuses on cattle, poultry, swine, aquaculture, regional disease control, and international market access. Canada combines livestock and companion-animal needs with surveillance, cold-climate logistics, and strong regulatory oversight. China is addressing large-scale production, disease prevention, domestic capability, and modernization of veterinary services. France, Germany, Italy, and Spain operate within the European regulatory framework while responding to livestock, companion-animal, welfare, and biosecurity priorities. India faces extensive livestock diversity, uneven veterinary access, and major needs in preventive coverage and rural delivery. Japan emphasizes advanced quality standards, aging demographics, companion-animal care, and preparedness for animal disease events. Mexico balances livestock production, cross-border trade, and access across varied regions. Russia's priorities include domestic production capacity, animal disease control, and geographically broad distribution. South Korea combines intensive production, strict biosecurity, and technologically enabled veterinary care. The United Kingdom focuses on biosecurity, surveillance, regulatory assurance, and animal welfare. The United States has broad demand across livestock, poultry, aquaculture, and companion animals, supported by sophisticated regulation, diagnostics, and disease-management programs.

Actions for Leaders: Build Resilient, Evidence-Based Prevention Systems

Industry leaders should align product development with clearly defined disease-control outcomes, species-specific use cases, and regulatory evidence requirements. Strengthening formulation stability, cold-chain performance, local technical support, and training can improve adoption where delivery infrastructure is uneven. Partnerships with veterinary authorities, laboratories, producers, universities, and public-health organizations can improve surveillance and response coordination. Leaders should also establish transparent stewardship policies, post-market monitoring, responsible data governance, and AI validation protocols. Portfolio resilience requires attention to critical inputs, manufacturing continuity, regional registration pathways, and contingency plans for outbreaks and logistics disruptions.

Research Methodology: Structured Review of Verified Market Evidence

This executive summary is based on the defined veterinary biological product category and the required regional, group, and country coverage. The analysis uses a structured framework linking product applications with disease prevention, veterinary infrastructure, regulation, trade, biosecurity, One Health priorities, and technology adoption. Geographic observations are presented qualitatively and are limited to established market drivers and operating conditions. No market estimates, market sizing, market shares, forecasts, or company-specific claims are included. Interpretations should be validated against current legislation, official disease surveillance, veterinary authorities, and product registration records before strategic decisions are made.

Conclusion: Prevention and System Integration Define Future Competitiveness

Veterinary biological products are becoming more central to resilient animal-health systems because they connect disease prevention, food security, animal welfare, zoonotic-risk management, and responsible antimicrobial use. Regional and country conditions remain highly varied, making adaptable products, reliable delivery systems, strong evidence, and regulatory alignment essential. Organizations that combine scientific rigor with surveillance, digital capability, local partnerships, and supply-chain resilience will be better positioned to support effective, sustainable animal-health outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Veterinary Biological Product Market, by Product Type

  • 7.1. Introduction
  • 7.2. Antitoxins
  • 7.3. Diagnostics
  • 7.4. Vaccines

8. Veterinary Biological Product Market, by Animal Type

  • 8.1. Introduction
  • 8.2. Aquaculture
  • 8.3. Companion Animals
    • 8.3.1. Canine
    • 8.3.2. Equine
    • 8.3.3. Feline
  • 8.4. Livestock
    • 8.4.1. Bovine
    • 8.4.2. Caprine
    • 8.4.3. Ovine
    • 8.4.4. Porcine
  • 8.5. Poultry

9. Veterinary Biological Product Market, by Disease Indication

  • 9.1. Introduction
  • 9.2. Bacterial Diseases
    • 9.2.1. Anthrax
    • 9.2.2. Brucellosis
    • 9.2.3. Salmonellosis
  • 9.3. Parasitic Diseases
  • 9.4. Viral Diseases
    • 9.4.1. Foot And Mouth Disease
    • 9.4.2. Newcastle Disease
    • 9.4.3. Rabies

10. Veterinary Biological Product Market, by End User

  • 10.1. Introduction
  • 10.2. Clinics
  • 10.3. Farmers
  • 10.4. Government Agencies
  • 10.5. Veterinary Hospitals

11. Veterinary Biological Product Market, by Route Of Administration

  • 11.1. Introduction
  • 11.2. Injection
    • 11.2.1. Intramuscular
    • 11.2.2. Intravenous
    • 11.2.3. Subcutaneous
  • 11.3. Nasal
  • 11.4. Oral

12. Veterinary Biological Product Market, by Region

  • 12.1. Introduction
  • 12.2. Asia-Pacific
  • 12.3. North America
  • 12.4. Latin America
  • 12.5. Europe
  • 12.6. Middle East
  • 12.7. Africa

13. Veterinary Biological Product Market, by Group

  • 13.1. Introduction
  • 13.2. ASEAN
  • 13.3. GCC
  • 13.4. European Union
  • 13.5. BRICS
  • 13.6. G7
  • 13.7. NATO

14. Veterinary Biological Product Market, by Country

  • 14.1. Introduction
  • 14.2. United States
  • 14.3. Canada
  • 14.4. Mexico
  • 14.5. Brazil
  • 14.6. United Kingdom
  • 14.7. Germany
  • 14.8. France
  • 14.9. Russia
  • 14.10. Italy
  • 14.11. Spain
  • 14.12. China
  • 14.13. India
  • 14.14. Japan
  • 14.15. Australia
  • 14.16. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. Market Concentration Analysis, 2025
    • 15.2.1. Concentration Ratio (CR)
    • 15.2.2. Herfindahl Hirschman Index (HHI)
  • 15.3. Recent Developments & Impact Analysis, 2025
  • 15.4. Product Portfolio Analysis, 2025
  • 15.5. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Animalcare Ltd
  • 16.2. Bimeda Inc
  • 16.3. Biogenesis Bago SA
  • 16.4. Boehringer Ingelheim International GmbH
  • 16.5. Ceva Sante Animale
  • 16.6. Chongqing Zhifei Biological Products Co Ltd
  • 16.7. Dechra Pharmaceuticals plc
  • 16.8. Eco Animal Health Group Limited
  • 16.9. Elanco Animal Health Incorporated
  • 16.10. Hester Biosciences Ltd
  • 16.11. HIPRA SA
  • 16.12. Indian Immunologicals Ltd
  • 16.13. Kyoritsu Seiyaku Corporation
  • 16.14. Merck & Co Inc
  • 16.15. Neogen Corporation
  • 16.16. Norbrook Laboratories Ltd
  • 16.17. Phibro Animal Health Corporation
  • 16.18. Shenzhen Kangtai Biological Products Co Ltd
  • 16.19. Tianjin Ringpu Bio-Technology Co Ltd
  • 16.20. Utrecht Biologicals BV
  • 16.21. Vetanco SA
  • 16.22. Vetoquinol SA
  • 16.23. Virbac SA
  • 16.24. Zoetis Inc

17. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Veterinary Biological Product Market, Years Considered for the Study
  • FIGURE 2. Global Veterinary Biological Product Market, Research Design
  • FIGURE 3. Global Veterinary Biological Product Market, Research Framework
  • FIGURE 4. Global Veterinary Biological Product Market, Data Triangulation
  • FIGURE 5. Global Veterinary Biological Product Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Veterinary Biological Product Market Size, by Product Type, 2025 vs 2032 (%)
  • FIGURE 7. Global Veterinary Biological Product Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Veterinary Biological Product Market Size, by Animal Type, 2025 vs 2032 (%)
  • FIGURE 9. Global Veterinary Biological Product Market Size, by Animal Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Veterinary Biological Product Market Size, by Disease Indication, 2025 vs 2032 (%)
  • FIGURE 11. Global Veterinary Biological Product Market Size, by Disease Indication, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Veterinary Biological Product Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 13. Global Veterinary Biological Product Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Veterinary Biological Product Market Size, by Route Of Administration, 2025 vs 2032 (%)
  • FIGURE 15. Global Veterinary Biological Product Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Veterinary Biological Product Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 17. Global Veterinary Biological Product Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global Veterinary Biological Product Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Veterinary Biological Product Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 20. Global Veterinary Biological Product Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 21. Global Veterinary Biological Product Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Veterinary Biological Product Market Segmentation & Coverage
  • TABLE 2. Global Veterinary Biological Product Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Veterinary Biological Product Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 4. Global Antitoxins Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Antitoxins Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Antitoxins Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Diagnostics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Diagnostics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Diagnostics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Vaccines Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Vaccines Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Vaccines Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Veterinary Biological Product Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 14. Global Aquaculture Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 15. Global Aquaculture Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 16. Global Aquaculture Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 17. Global Companion Animals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 18. Global Companion Animals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 19. Global Companion Animals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 20. Global Canine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 21. Global Canine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 22. Global Canine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 23. Global Equine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 24. Global Equine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 25. Global Equine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 26. Global Feline Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 27. Global Feline Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 28. Global Feline Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 29. Global Livestock Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 30. Global Livestock Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 31. Global Livestock Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 32. Global Bovine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 33. Global Bovine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 34. Global Bovine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 35. Global Caprine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 36. Global Caprine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 37. Global Caprine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 38. Global Ovine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 39. Global Ovine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 40. Global Ovine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 41. Global Porcine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 42. Global Porcine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 43. Global Porcine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 44. Global Poultry Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 45. Global Poultry Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 46. Global Poultry Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 47. Global Veterinary Biological Product Market Size, by Disease Indication, 2017-2032 (USD Million)
  • TABLE 48. Global Bacterial Diseases Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 49. Global Bacterial Diseases Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 50. Global Bacterial Diseases Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 51. Global Anthrax Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 52. Global Anthrax Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 53. Global Anthrax Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 54. Global Brucellosis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 55. Global Brucellosis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 56. Global Brucellosis Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 57. Global Salmonellosis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 58. Global Salmonellosis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 59. Global Salmonellosis Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 60. Global Parasitic Diseases Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 61. Global Parasitic Diseases Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 62. Global Parasitic Diseases Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 63. Global Viral Diseases Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 64. Global Viral Diseases Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 65. Global Viral Diseases Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 66. Global Foot And Mouth Disease Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 67. Global Foot And Mouth Disease Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 68. Global Foot And Mouth Disease Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 69. Global Newcastle Disease Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 70. Global Newcastle Disease Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 71. Global Newcastle Disease Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 72. Global Rabies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 73. Global Rabies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 74. Global Rabies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 75. Global Veterinary Biological Product Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 76. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 77. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 78. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 79. Global Farmers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 80. Global Farmers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 81. Global Farmers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 82. Global Government Agencies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 83. Global Government Agencies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 84. Global Government Agencies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 85. Global Veterinary Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 86. Global Veterinary Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 87. Global Veterinary Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 88. Global Veterinary Biological Product Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 89. Global Injection Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 90. Global Injection Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 91. Global Injection Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 92. Global Intramuscular Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 93. Global Intramuscular Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 94. Global Intramuscular Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 95. Global Intravenous Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 96. Global Intravenous Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 97. Global Intravenous Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 98. Global Subcutaneous Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 99. Global Subcutaneous Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 100. Global Subcutaneous Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 101. Global Nasal Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 102. Global Nasal Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 103. Global Nasal Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 104. Global Oral Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 105. Global Oral Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 106. Global Oral Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 107. Global Veterinary Biological Product Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 108. Asia-Pacific Veterinary Biological Product Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 109. Asia-Pacific Veterinary Biological Product Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 110. Asia-Pacific Veterinary Biological Product Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 111. Asia-Pacific Veterinary Biological Product Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 112. Asia-Pacific Veterinary Biological Product Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 113. Asia-Pacific Veterinary Biological Product Market Size, by Disease Indication, 2017-2032 (USD Million)
  • TABLE 114. Asia-Pacific Veterinary Biological Product Market Size, by Bacterial Diseases, 2017-2032 (USD Million)
  • TABLE 115. Asia-Pacific Veterinary Biological Product Market Size, by Viral Diseases, 2017-2032 (USD Million)
  • TABLE 116. Asia-Pacific Veterinary Biological Product Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 117. Asia-Pacific Veterinary Biological Product Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 118. Asia-Pacific Veterinary Biological Product Market Size, by Injection, 2017-2032 (USD Million)
  • TABLE 119. North America Veterinary Biological Product Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 120. North America Veterinary Biological Product Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 121. North America Veterinary Biological Product Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 122. North America Veterinary Biological Product Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 123. North America Veterinary Biological Product Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 124. North America Veterinary Biological Product Market Size, by Disease Indication, 2017-2032 (USD Million)
  • TABLE 125. North America Veterinary Biological Product Market Size, by Bacterial Diseases, 2017-2032 (USD Million)
  • TABLE 126. North America Veterinary Biological Product Market Size, by Viral Diseases, 2017-2032 (USD Million)
  • TABLE 127. North America Veterinary Biological Product Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 128. North America Veterinary Biological Product Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 129. North America Veterinary Biological Product Market Size, by Injection, 2017-2032 (USD Million)
  • TABLE 130. Latin America Veterinary Biological Product Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 131. Latin America Veterinary Biological Product Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 132. Latin America Veterinary Biological Product Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 133. Latin America Veterinary Biological Product Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 134. Latin America Veterinary Biological Product Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 135. Latin America Veterinary Biological Product Market Size, by Disease Indication, 2017-2032 (USD Million)
  • TABLE 136. Latin America Veterinary Biological Product Market Size, by Bacterial Diseases, 2017-2032 (USD Million)
  • TABLE 137. Latin America Veterinary Biological Product Market Size, by Viral Diseases, 2017-2032 (USD Million)
  • TABLE 138. Latin America Veterinary Biological Product Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 139. Latin America Veterinary Biological Product Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 140. Latin America Veterinary Biological Product Market Size, by Injection, 2017-2032 (USD Million)
  • TABLE 141. Europe Veterinary Biological Product Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 142. Europe Veterinary Biological Product Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 143. Europe Veterinary Biological Product Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 144. Europe Veterinary Biological Product Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 145. Europe Veterinary Biological Product Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 146. Europe Veterinary Biological Product Market Size, by Disease Indication, 2017-2032 (USD Million)
  • TABLE 147. Europe Veterinary Biological Product Market Size, by Bacterial Diseases, 2017-2032 (USD Million)
  • TABLE 148. Europe Veterinary Biological Product Market Size, by Viral Diseases, 2017-2032 (USD Million)
  • TABLE 149. Europe Veterinary Biological Product Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 150. Europe Veterinary Biological Product Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 151. Europe Veterinary Biological Product Market Size, by Injection, 2017-2032 (USD Million)
  • TABLE 152. Middle East Veterinary Biological Product Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 153. Middle East Veterinary Biological Product Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 154. Middle East Veterinary Biological Product Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 155. Middle East Veterinary Biological Product Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 156. Middle East Veterinary Biological Product Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 157. Middle East Veterinary Biological Product Market Size, by Disease Indication, 2017-2032 (USD Million)
  • TABLE 158. Middle East Veterinary Biological Product Market Size, by Bacterial Diseases, 2017-2032 (USD Million)
  • TABLE 159. Middle East Veterinary Biological Product Market Size, by Viral Diseases, 2017-2032 (USD Million)
  • TABLE 160. Middle East Veterinary Biological Product Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 161. Middle East Veterinary Biological Product Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 162. Middle East Veterinary Biological Product Market Size, by Injection, 2017-2032 (USD Million)
  • TABLE 163. Africa Veterinary Biological Product Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 164. Africa Veterinary Biological Product Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 165. Africa Veterinary Biological Product Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 166. Africa Veterinary Biological Product Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 167. Africa Veterinary Biological Product Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 168. Africa Veterinary Biological Product Market Size, by Disease Indication, 2017-2032 (USD Million)
  • TABLE 169. Africa Veterinary Biological Product Market Size, by Bacterial Diseases, 2017-2032 (USD Million)
  • TABLE 170. Africa Veterinary Biological Product Market Size, by Viral Diseases, 2017-2032 (USD Million)
  • TABLE 171. Africa Veterinary Biological Product Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 172. Africa Veterinary Biological Product Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 173. Africa Veterinary Biological Product Market Size, by Injection, 2017-2032 (USD Million)
  • TABLE 174. Global Veterinary Biological Product Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 175. ASEAN Veterinary Biological Product Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 176. ASEAN Veterinary Biological Product Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 177. ASEAN Veterinary Biological Product Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 178. ASEAN Veterinary Biological Product Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 179. ASEAN Veterinary Biological Product Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 180. ASEAN Veterinary Biological Product Market Size, by Disease Indication, 2017-2032 (USD Million)
  • TABLE 181. ASEAN Veterinary Biological Product Market Size, by Bacterial Diseases, 2017-2032 (USD Million)
  • TABLE 182. ASEAN Veterinary Biological Product Market Size, by Viral Diseases, 2017-2032 (USD Million)
  • TABLE 183. ASEAN Veterinary Biological Product Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 184. ASEAN Veterinary Biological Product Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 185. ASEAN Veterinary Biological Product Market Size, by Injection, 2017-2032 (USD Million)
  • TABLE 186. GCC Veterinary Biological Product Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 187. GCC Veterinary Biological Product Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 188. GCC Veterinary Biological Product Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 189. GCC Veterinary Biological Product Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 190. GCC Veterinary Biological Product Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 191. GCC Veterinary Biological Product Market Size, by Disease Indication, 2017-2032 (USD Million)
  • TABLE 192. GCC Veterinary Biological Product Market Size, by Bacterial Diseases, 2017-2032 (USD Million)
  • TABLE 193. GCC Veterinary Biological Product Market Size, by Viral Diseases, 2017-2032 (USD Million)
  • TABLE 194. GCC Veterinary Biological Product Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 195. GCC Veterinary Biological Product Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 196. GCC Veterinary Biological Product Market Size, by Injection, 2017-2032 (USD Million)
  • TABLE 197. European Union Veterinary Biological Product Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 198. European Union Veterinary Biological Product Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 199. European Union Veterinary Biological Product Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 200. European Union Veterinary Biological Product Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 201. European Union Veterinary Biological Product Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 202. European Union Veterinary Biological Product Market Size, by Disease Indication, 2017-2032 (USD Million)
  • TABLE 203. European Union Veterinary Biological Product Market Size, by Bacterial Diseases, 2017-2032 (USD Million)
  • TABLE 204. European Union Veterinary Biological Product Market Size, by Viral Diseases, 2017-2032 (USD Million)
  • TABLE 205. European Union Veterinary Biological Product Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 206. European Union Veterinary Biological Product Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 207. European Union Veterinary Biological Product Market Size, by Injection, 2017-2032 (USD Million)
  • TABLE 208. BRICS Veterinary Biological Product Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 209. BRICS Veterinary Biological Product Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 210. BRICS Veterinary Biological Product Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 211. BRICS Veterinary Biological Product Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 212. BRICS Veterinary Biological Product Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 213. BRICS Veterinary Biological Product Market Size, by Disease Indication, 2017-2032 (USD Million)
  • TABLE 214. BRICS Veterinary Biological Product Market Size, by Bacterial Diseases, 2017-2032 (USD Million)
  • TABLE 215. BRICS Veterinary Biological Product Market Size, by Viral Diseases, 2017-2032 (USD Million)
  • TABLE 216. BRICS Veterinary Biological Product Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 217. BRICS Veterinary Biological Product Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 218. BRICS Veterinary Biological Product Market Size, by Injection, 2017-2032 (USD Million)
  • TABLE 219. G7 Veterinary Biological Product Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 220. G7 Veterinary Biological Product Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 221. G7 Veterinary Biological Product Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 222. G7 Veterinary Biological Product Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 223. G7 Veterinary Biological Product Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 224. G7 Veterinary Biological Product Market Size, by Disease Indication, 2017-2032 (USD Million)
  • TABLE 225. G7 Veterinary Biological Product Market Size, by Bacterial Diseases, 2017-2032 (USD Million)
  • TABLE 226. G7 Veterinary Biological Product Market Size, by Viral Diseases, 2017-2032 (USD Million)
  • TABLE 227. G7 Veterinary Biological Product Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 228. G7 Veterinary Biological Product Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 229. G7 Veterinary Biological Product Market Size, by Injection, 2017-2032 (USD Million)
  • TABLE 230. NATO Veterinary Biological Product Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 231. NATO Veterinary Biological Product Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 232. NATO Veterinary Biological Product Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 233. NATO Veterinary Biological Product Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 234. NATO Veterinary Biological Product Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 235. NATO Veterinary Biological Product Market Size, by Disease Indication, 2017-2032 (USD Million)
  • TABLE 236. NATO Veterinary Biological Product Market Size, by Bacterial Diseases, 2017-2032 (USD Million)
  • TABLE 237. NATO Veterinary Biological Product Market Size, by Viral Diseases, 2017-2032 (USD Million)
  • TABLE 238. NATO Veterinary Biological Product Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 239. NATO Veterinary Biological Product Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 240. NATO Veterinary Biological Product Market Size, by Injection, 2017-2032 (USD Million)
  • TABLE 241. Global Veterinary Biological Product Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 242. United States Veterinary Biological Product Market Size, 2017-2032 (USD Million)
  • TABLE 243. United States Veterinary Biological Product Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 244. United States Veterinary Biological Product Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 245. United States Veterinary Biological Product Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 246. United States Veterinary Biological Product Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 247. United States Veterinary Biological Product Market Size, by Disease Indication, 2017-2032 (USD Million)
  • TABLE 248. United States Veterinary Biological Product Market Size, by Bacterial Diseases, 2017-2032 (USD Million)
  • TABLE 249. United States Veterinary Biological Product Market Size, by Viral Diseases, 2017-2032 (USD Million)
  • TABLE 250. United States Veterinary Biological Product Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 251. United States Veterinary Biological Product Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 252. United States Veterinary Biological Product Market Size, by Injection, 2017-2032 (USD Million)
  • TABLE 253. Canada Veterinary Biological Product Market Size, 2017-2032 (USD Million)
  • TABLE 254. Canada Veterinary Biological Product Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 255. Canada Veterinary Biological Product Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 256. Canada Veterinary Biological Product Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 257. Canada Veterinary Biological Product Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 258. Canada Veterinary Biological Product Market Size, by Disease Indication, 2017-2032 (USD Million)
  • TABLE 259. Canada Veterinary Biological Product Market Size, by Bacterial Diseases, 2017-2032 (USD Million)
  • TABLE 260. Canada Veterinary Biological Product Market Size, by Viral Diseases, 2017-2032 (USD Million)
  • TABLE 261. Canada Veterinary Biological Product Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 262. Canada Veterinary Biological Product Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 263. Canada Veterinary Biological Product Market Size, by Injection, 2017-2032 (USD Million)
  • TABLE 264. Mexico Veterinary Biological Product Market Size, 2017-2032 (USD Million)
  • TABLE 265. Mexico Veterinary Biological Product Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 266. Mexico Veterinary Biological Product Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 267. Mexico Veterinary Biological Product Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 268. Mexico Veterinary Biological Product Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 269. Mexico Veterinary Biological Product Market Size, by Disease Indication, 2017-2032 (USD Million)
  • TABLE 270. Mexico Veterinary Biological Product Market Size, by Bacterial Diseases, 2017-2032 (USD Million)
  • TABLE 271. Mexico Veterinary Biological Product Market Size, by Viral Diseases, 2017-2032 (USD Million)
  • TABLE 272. Mexico Veterinary Biological Product Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 273. Mexico Veterinary Biological Product Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 274. Mexico Veterinary Biological Product Market Size, by Injection, 2017-2032 (USD Million)
  • TABLE 275. Brazil Veterinary Biological Product Market Size, 2017-2032 (USD Million)
  • TABLE 276. Brazil Veterinary Biological Product Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 277. Brazil Veterinary Biological Product Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 278. Brazil Veterinary Biological Product Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 279. Brazil Veterinary Biological Product Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 280. Brazil Veterinary Biological Product Market Size, by Disease Indication, 2017-2032 (USD Million)
  • TABLE 281. Brazil Veterinary Biological Product Market Size, by Bacterial Diseases, 2017-2032 (USD Million)
  • TABLE 282. Brazil Veterinary Biological Product Market Size, by Viral Diseases, 2017-2032 (USD Million)
  • TABLE 283. Brazil Veterinary Biological Product Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 284. Brazil Veterinary Biological Product Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 285. Brazil Veterinary Biological Product Market Size, by Injection, 2017-2032 (USD Million)
  • TABLE 286. United Kingdom Veterinary Biological Product Market Size, 2017-2032 (USD Million)
  • TABLE 287. United Kingdom Veterinary Biological Product Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 288. United Kingdom Veterinary Biological Product Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 289. United Kingdom Veterinary Biological Product Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 290. United Kingdom Veterinary Biological Product Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 291. United Kingdom Veterinary Biological Product Market Size, by Disease Indication, 2017-2032 (USD Million)
  • TABLE 292. United Kingdom Veterinary Biological Product Market Size, by Bacterial Diseases, 2017-2032 (USD Million)
  • TABLE 293. United Kingdom Veterinary Biological Product Market Size, by Viral Diseases, 2017-2032 (USD Million)
  • TABLE 294. United Kingdom Veterinary Biological Product Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 295. United Kingdom Veterinary Biological Product Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 296. United Kingdom Veterinary Biological Product Market Size, by Injection, 2017-2032 (USD Million)
  • TABLE 297. Germany Veterinary Biological Product Market Size, 2017-2032 (USD Million)
  • TABLE 298. Germany Veterinary Biological Product Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 299. Germany Veterinary Biological Product Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 300. Germany Veterinary Biological Product Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 301. Germany Veterinary Biological Product Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 302. Germany Veterinary Biological Product Market Size, by Disease Indication, 2017-2032 (USD Million)
  • TABLE 303. Germany Veterinary Biological Product Market Size, by Bacterial Diseases, 2017-2032 (USD Million)
  • TABLE 304. Germany Veterinary Biological Product Market Size, by Viral Diseases, 2017-2032 (USD Million)
  • TABLE 305. Germany Veterinary Biological Product Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 306. Germany Veterinary Biological Product Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 307. Germany Veterinary Biological Product Market Size, by Injection, 2017-2032 (USD Million)
  • TABLE 308. France Veterinary Biological Product Market Size, 2017-2032 (USD Million)
  • TABLE 309. France Veterinary Biological Product Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 310. France Veterinary Biological Product Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 311. France Veterinary Biological Product Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 312. France Veterinary Biological Product Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 313. France Veterinary Biological Product Market Size, by Disease Indication, 2017-2032 (USD Million)
  • TABLE 314. France Veterinary Biological Product Market Size, by Bacterial Diseases, 2017-2032 (USD Million)
  • TABLE 315. France Veterinary Biological Product Market Size, by Viral Diseases, 2017-2032 (USD Million)
  • TABLE 316. France Veterinary Biological Product Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 317. France Veterinary Biological Product Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 318. France Veterinary Biological Product Market Size, by Injection, 2017-2032 (USD Million)
  • TABLE 319. Russia Veterinary Biological Product Market Size, 2017-2032 (USD Million)
  • TABLE 320. Russia Veterinary Biological Product Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 321. Russia Veterinary Biological Product Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 322. Russia Veterinary Biological Product Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 323. Russia Veterinary Biological Product Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 324. Russia Veterinary Biological Product Market Size, by Disease Indication, 2017-2032 (USD Million)
  • TABLE 325. Russia Veterinary Biological Product Market Size, by Bacterial Diseases, 2017-2032 (USD Million)
  • TABLE 326. Russia Veterinary Biological Product Market Size, by Viral Diseases, 2017-2032 (USD Million)
  • TABLE 327. Russia Veterinary Biological Product Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 328. Russia Veterinary Biological Product Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 329. Russia Veterinary Biological Product Market Size, by Injection, 2017-2032 (USD Million)
  • TABLE 330. Italy Veterinary Biological Product Market Size, 2017-2032 (USD Million)
  • TABLE 331. Italy Veterinary Biological Product Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 332. Italy Veterinary Biological Product Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 333. Italy Veterinary Biological Product Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 334. Italy Veterinary Biological Product Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 335. Italy Veterinary Biological Product Market Size, by Disease Indication, 2017-2032 (USD Million)
  • TABLE 336. Italy Veterinary Biological Product Market Size, by Bacterial Diseases, 2017-2032 (USD Million)
  • TABLE 337. Italy Veterinary Biological Product Market Size, by Viral Diseases, 2017-2032 (USD Million)
  • TABLE 338. Italy Veterinary Biological Product Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 339. Italy Veterinary Biological Product Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 340. Italy Veterinary Biological Product Market Size, by Injection, 2017-2032 (USD Million)
  • TABLE 341. Spain Veterinary Biological Product Market Size, 2017-2032 (USD Million